Endothelin-1 and brain natriuretic peptide plasma levels decrease after aortic surgery.
暂无分享,去创建一个
A. Franco‐Cereceda | P. Eriksson | M. Eriksson | J. Liska | K. Caidahl | G. Raffa | Veronica Jackson | J. Líška | A. Franco-Cereceda
[1] A. Gottsäter,et al. High Levels of Endothelin (ET)-1 and Aneurysm Diameter Independently Predict Growth of Stable Abdominal Aortic Aneurysms , 2010, Angiology.
[2] J. Toole,et al. Selective endothelin-1 receptor type A inhibition in subjects undergoing cardiac surgery with preexisting left ventricular dysfunction: Influence on early postoperative hemodynamics. , 2010, The Journal of thoracic and cardiovascular surgery.
[3] Y. Soini,et al. Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis. , 2008, European heart journal.
[4] A. Kerr,et al. B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation , 2007, Heart.
[5] J. Pernow,et al. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. , 2007, Cardiovascular research.
[6] H. Baumgartner,et al. Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure. , 2006, International journal of cardiology.
[7] S. Ray,et al. Natriuretic peptides in heart valve disease , 2005, Heart.
[8] K. Chatterjee. Neurohormonal activation in congestive heart failure and the role of vasopressin. , 2005, The American journal of cardiology.
[9] J. Bartunek,et al. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[10] C. Hamm,et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. , 2004, The American journal of cardiology.
[11] R. Bonow,et al. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. , 2004, The American journal of cardiology.
[12] J. Cohn,et al. Ventricular remodeling in heart failure: a credible surrogate endpoint. , 2003, Journal of cardiac failure.
[13] H. White,et al. Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation. , 2003, The American journal of cardiology.
[14] M. Drazner,et al. B-type natriuretic peptide in cardiovascular disease , 2003, The Lancet.
[15] J. Rouleau,et al. Role of endothelins in congestive heart failure. , 2003, Canadian journal of physiology and pharmacology.
[16] N. Fukuda,et al. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. , 2003, The Journal of heart valve disease.
[17] H. White,et al. Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis , 2003, Circulation.
[18] M. Holzer,et al. Plasma endothelin in patients with acute aortic disease. , 2002, Resuscitation.
[19] P. Mathisen,et al. The effect of aortic valve replacement on N‐terminal natriuretic propeptides in patients with aortic stenosis , 2002, Clinical cardiology.
[20] P. Mathisen,et al. Natriuretic peptides in patients with aortic stenosis. , 2001, American heart journal.
[21] D. Barnett,et al. Plasma N‐terminal pro BNP and cardiotrophin‐1 are elevated in aortic stenosis , 2001, European journal of heart failure.
[22] A. Linhart,et al. [Humoral profile of patients with severe aortic stenosis]. , 2000, Casopis lekaru ceskych.
[23] I. Yamaguchi,et al. Effects of physiological or pathological pressure load in vivo on myocardial expression of ET-1 and receptors. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[24] S. Vanni,et al. Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. , 1999, Circulation research.
[25] N. Prasada,et al. Brain natriuretic peptide concentrations in patients with aortic stenosis , 1997 .
[26] M. Komajda,et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. , 1997, European heart journal.
[27] L. Jensen,et al. Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease. , 1996, Blood pressure.
[28] Y. Sugishita,et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. , 1993, Circulation research.
[29] Y. Sugishita,et al. Increased production of endothelin‐1 in the hypertrophied rat heart due to pressure overload , 1993, FEBS letters.
[30] A. Carayon,et al. [Neurohormonal profile in aortic valve stenosis]. , 1993, Archives des maladies du coeur et des vaisseaux.
[31] Naoto Minamino,et al. A new natriuretic peptide in porcine brain , 1988, Nature.
[32] R. Paul,et al. Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. , 1985, The American journal of physiology.